Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 1 October 2027
- Last conf. stmt
- 17 September 2026
Stiefel Laboratories (U.K.) Ltd
- Incorporated
- 15 December 1964 (61 years)
- Industry
- Non-trading company (74990)
- Accounts type
- Audit exemption subsidiary
- Region
- Greater London
- Address
- 79 New Oxford StreetLondonWC1A 1DG
Officers 4 active
Officer details are public data from the Companies House register.
Director · Appointed 11 January 2022
British,French
Born May 1965 (61)
Corporate Secretary · Appointed 15 April 2010
Corporate Director · Appointed 23 July 2009
Corporate Director · Appointed 23 July 2009
Officer history (23 former)
11 January 2022
11 January 2022
2 March 2020
2 March 2020
Resigned Latchford, Richard John as Director
2 March 2020
28 June 2019
Resigned Surve, Sheryl Vikas, Dr as Director
25 April 2019
Appointed Latchford, Richard John as Director
15 February 2019
19 January 2018
Resigned Walters, David John as Director
19 January 2018
Appointed Surve, Sheryl Vikas, Dr as Director
29 January 2016
30 August 2015
Appointed Walters, David John as Director
21 February 2011
Resigned Jaitly, Seema, Dr as Director
31 May 2010
Resigned Waucquez, Pascal as Director
15 April 2010
31 March 2010
Resigned Devine, David William as Secretary
31 March 2010
Resigned Devine, David William as Director
31 March 2010
Resigned Zdanowicz, Margaret Eithne as Director
23 July 2009
23 July 2009
31 March 2009
Appointed Devine, David William as Director
31 March 2009
Resigned Warburton, Frederick John as Director
13 February 2009
Appointed Jaitly, Seema, Dr as Director
20 July 2007
Resigned Zdanowicz, Margaret Eithne as Secretary
1 February 2007
Appointed Waucquez, Pascal as Director
1 February 2007
Resigned Stiefel, Charles as Director
2 January 2007
Appointed Devine, David William as Secretary
31 December 2006
Resigned David, Brian Thomas as Director
1 October 2006
Appointed Stiefel, Charles as Director
30 September 2006
31 December 2003
Resigned Stubbs, Laurence as Director
30 September 2002
Resigned Bertram, Bruno as Director
30 June 2000
Resigned Trinder, Colin as Director
1 July 1999
1 July 1999
Appointed Stubbs, Laurence as Director
1 April 1998
Appointed Zdanowicz, Margaret Eithne as Director
1 April 1998
Appointed Warburton, Frederick John as Director
1 April 1998
Appointed Trinder, Colin as Director
31 March 1998
Resigned Skinner, Brian John as Director
17 July 1997
Appointed Zdanowicz, Margaret Eithne as Secretary
12 June 1997
Resigned Hobbs, Michael as Secretary
31 May 1996
17 January 1995
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 19 August 2021
Owns 25–50% of shares
Holds 25–50% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 11724333
Corporate entity · Notified 6 April 2016
Owns 50–75% of shares
Holds 50–75% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 2332323
Former controllers (1)
19 August 2021
Ceased Glaxosmithkline Finance PLC — Owns 25–50% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 17 September 2026 | Confirmation statement with no updates | 17 September 2026 | ||
| 24 June 2026 | Notification of a person with significant control | |||
| 24 June 2026 | Cessation of a person with significant control | |||
| 24 May 2026 | Other filing | |||
| 24 May 2026 | Other filing |
Some other companies at this address
Other companies in this industry
London
London
High Wycombe
Lincoln
Stadhampton
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →